Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

about

The cognitive profile of prion disease: a prospective clinical and imaging study.Therapeutic approaches for prion disorders.Variant Creutzfeldt-Jakob disease: neuropsychological profile in an extended series of cases.High mortality of subjects with endemic ataxic polyneuropathy in Nigeria.

P2860

Q35619208-AAC4F56F-C912-4256-ADD7-64F411D40A55 Q36901944-E081730B-3D6E-4C0F-A12B-0ED8B91929D4 Q44853053-FF4813DF-3D7D-4712-9F54-EACBDF68E9FC Q50638463-3F12F300-5728-4D50-A2EF-7FAFA6AC7471

P2860

Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

Item

http://www.wikidata.org/entity/Q35560261

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Early cognitive decline in Cre ...... uman growth hormone treatment.

@ast

Early cognitive decline in Cre ...... uman growth hormone treatment.

@en

type

Item

label

Early cognitive decline in Cre ...... uman growth hormone treatment.

@ast

Early cognitive decline in Cre ...... uman growth hormone treatment.

@en

prefLabel

Early cognitive decline in Cre ...... uman growth hormone treatment.

@ast

Early cognitive decline in Cre ...... uman growth hormone treatment.

@en

P1476

Early cognitive decline in Cre ...... human growth hormone treatment

@en

P2093

D G O'Donovan

http://www.w3.org/2001/XMLSchema#string

L Cipolotti

http://www.w3.org/2001/XMLSchema#string

L Davidson

http://www.w3.org/2001/XMLSchema#string

M Hall

http://www.w3.org/2001/XMLSchema#string

P Adlard

http://www.w3.org/2001/XMLSchema#string

R J Cordery

http://www.w3.org/2001/XMLSchema#string

S Al-Sarraj

http://www.w3.org/2001/XMLSchema#string

P2860

Iatrogenic Creutzfeldt-Jakob disease at the millennium.

The cerebellar cognitive affective syndrome.

"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Evidence for case-to-case transmission of Creutzfeldt-Jakob disease

Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration.

Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France.

Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease.

A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.

Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

P304

1412-1416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.74.10.1412

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Rossor

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231586088

http://www.w3.org/2001/XMLSchema#string

P698

14570836

http://www.w3.org/2001/XMLSchema#string

P932

1757404

http://www.w3.org/2001/XMLSchema#string

Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

about

P2860

P2860

Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932